Tirzepatide is a medication prescribed to address type 2 diabetes, obesity, or weight-related concerns by mimicking the effects of two hormones, GLP-1 and GIP
GLP-1 Market: Key Segments Currently, Small Molecule Segment Occupies the Largest Share of the GLP-1 Market In terms of type of molecule, the market is segmented into biologics and small molecules
A 2022 systematic review of randomized controlled trials confirms its effectiveness in improving signs of photoaging, including fine wrinkles, skin texture, and collagen formation
Weeks 1 through 4 use this initial dose to allow your body to recognize and respond to GLP-1 activation
Food and Drug Administration has granted Breakthrough Therapy Designation to our investigational glucagon/GLP-1 dual receptor agonist for the treatment of patients with metabolic dysfunction-associated steatohepatitis (MASH)